About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 133 record(s)
Req # A 2022_0021
January 1, 2022 to present, internal and consultant reports, governance structure plans, costs incurred to setting up and projected costs and budget projections for Canada Growth Fund. Include a breakdown of launching costs, of logo and branding costs/projections.Organization: Canada Development Investment Corporation
439 page(s)
November 2023
November 2023
Req # A-2022-00119
I request: (1) The type(s) of license(s) currently held by the Nova Scotia Capital District Health Authority; (2) The date(s) on which the Nova Scotia Capital District Health Authority first applied for a license to construct a Class II nuclear facility (3) The date(s) on which the Nova Scotia Capital District Health Authority first applied for a license to commission a Class II nuclear facility (4) The date(s) on which the Nova Scotia Capital District Health Authority first applied for a license to operate a Class II nuclear facility (5) The date(s) on which the Nova Scotia Capital District Health Authority first applied for a license to service Class II prescribed equipment (whether by operator or by a third party) (6) The date(s) on which the Nova Scotia Capital District Health Authority first applied for a license to operate Class II prescribed equipment (7) Whether and for what reason(s) the CNSC rejected any of the above application(s) (8) The response times of the CNSC in granting or declining to grant the above license(s) (9) Copies of all communications related to the above-mentioned applications as between the Nova Scotia Capital District Health Authority and the CNSCOrganization: Canadian Nuclear Safety Commission
577 page(s)
November 2023
November 2023
Req # A-2023-00054
All briefing materials, including and not limited to briefing notes, information notes, scenario notes, prepared and/or provided to the President in July 2023.Organization: Canadian Nuclear Safety Commission
299 page(s)
November 2023
November 2023
Req # A-2023-00065
A list of action items produced by the CNSC’s Executive Team in August 2023. Include any briefing materials including and not limited to: briefing notes, information notes, scenario notes; anything that the Executive Team has been briefed on in August 2023. Also include meeting minutes or agendas.Organization: Canadian Nuclear Safety Commission
332 page(s)
November 2023
November 2023
Req # A-2023-00070
A list of action items produced by the CNSC’s Executive Team in September 2023. Include any briefing materials including and not limited to: briefing notes, information notes, scenario notes; anything that the Executive Team has been briefed on in September 2023. Also include meeting minutes or agendas.Organization: Canadian Nuclear Safety Commission
89 page(s)
November 2023
November 2023
Req # A-2023-00073
Obtain copies of documents corresponding to the following description: 1- Invoices and/or vouchers for Rumina Velshi's meal expenses for her trip from May 18 to 27, 2019. 2- Invoices and/or supporting documents for the airline ticket purchased for Ms. Velshi for the flight from Toronto to Ottawa on or around October 31, 2022 (outbound) and November 3, 2022 (return). 3- Invoices and/or supporting documents for Ms. Velshi's airline ticket to Saskatoon on or about April 29, 2023 (outbound) and May 2, 2023 (return). If by some chance it is not possible to provide me with the invoices, please provide me with as much detail as possible on the expenses for these trips, either by transfer from the expense account or the credit card statement, if applicable.Organization: Canadian Nuclear Safety Commission
9 page(s)
November 2023
November 2023
Req # A-2023-00076
Alnwick Park Developments Inc. (the “Purchaser”) purchase from Patricia Foerderer and Willi Godfrie Foerderer (collectively, the “Vendor”) of the lands and premises legally described as PT LT 28 CON 5 OPS AS IN R293635; T/W R293635; KAWARTHA LAKES (being all of PIN 63203-0148 (LT)) and municipally known as 58 Maple Lane Drive, Kawartha Lakes (Lindsay), Ontario, K9V 4R1 (the “Property”) Our File No.: 3900-813Organization: Canadian Nuclear Safety Commission
0 page(s)
November 2023
November 2023
Req # A-2023-00026
All unclassified materials that went into the "Baseline Cyber Threat Assessment: Cybercrime" released by the CCCS in August 2023 pertaining to ransomware.Organization: Communications Security Establishment Canada
15 page(s)
November 2023
November 2023
Req # A-2021-000075
All records pertaining to the initial identification of something other than Creutzfeldt-Jakob Disease (CJD) in possible CJD referral cases in New Brunswick, that something was amiss or something inexplicable was happening. Date range: January 1, 2015 - May 11, 2021.Organization: Public Health Agency of Canada
114 page(s)
November 2023
November 2023
Req # A-2021-000365
Documents related to work on the isolation, description, classification and recording of the SARS-Cov-2 virus and its comparison to viruses and pathogens previously studied and referenced by the laboratory. Documents related to the laboratory's development of the reagent for detecting COVID-19 by public health laboratories in Canada. Documents related to the reagent's ability to detect the SARS-Cov-2 virus. Documents related to the laboratory's development of tests for detecting the SARS-Cov-2 virus and/or COVID-19. Documents related the review, analysis, benchmarking, comparison and validation of the various tests for detecting and screening COVID019 authorized by Health Canada, marketed and used across the country to detect COVID-19 and the SARS-Cov-2 virus. Documents related to the review, analysis and ability of diagnostic tests approved by Health Canada to detect the SARS-Cov-2 virus. Documents related to the laboratory's work in examining the correlation between the results of polymerase chain reaction (PCR) tests conducted, the estimation of viral load, the number of amplification cycles needed to detect the virus and the effective and isolated presence of the SARS-Cov-2 virus verified by culturing samples collected from individuals who had a positive result from a diagnostic test approved by Health Canada. Documents related to the laboratory's review, analysis and monitoring of the effectiveness of vaccines used in Canada to prevent and combat COVID-19 and the SARS-Cov-2 virus. Documents, data books and analyses related to the frequency of co-infections in samples collected from people with COVID-19 identified by laboratory culturing. Documents that identify, date and analyze culturing, samples from people declared positive for COVID-19, conducted since the start of 2020 by the laboratory and its annexes and provincial partners.Organization: Public Health Agency of Canada
1311 page(s)
November 2023
November 2023